ATHE (Alterity Therapeutics) Sof foyda

alteritytherapeutics.com (ATHE) kompaniyasining rasmiy ramzlari

Alterity Therapeutics (ATHE) kimyoviy chiqindilarni kamaytirgan holda, nevrologik dori vositalarini ishlab chiqishga ESG standartlari va bioetikani integratsiya qilmoqda. GURU.Markets platformasida kompaniyaning joriy foydasini tahlil qilib, biz joriy daraja -0.02 ekanligini ko'ramiz, bu esa ekologik barqarorlikni Altsgeymer va Parkinson kasalliklari uchun davolash vositalarini ishlab chiqish bilan bog'laydi. Biroq, daromadli aktivlar va operatsion pul oqimining yo'qligi biznesning mavjud naqd pul zaxiralariga bog'liqligini yuzaga keltirmoqda.

ATHE: alteritytherapeutics.com Sof daromad 04.07.2022 - 31.10.2026

alteritytherapeutics.com (ATHE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Alterity Therapeutics Limited|ATHE - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Alterity Therapeutics Limited|ATHE - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Alterity Therapeutics|ATHE - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori alteritytherapeutics.com|ATHE - Kompaniyaning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning kapitalga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics Limited|ATHE - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Alterity Therapeutics Limited|ATHE - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Alterity Therapeutics|Shoshilinch likvidlik alteritytherapeutics.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ATHE - Sof daromad
Fundamental baholash:ATHE - Alterity Therapeutics Ltd
Alterity Therapeutics Ltd. brend mahsuloti

Ushbu ko'rsatkich kunlik sof foyda va kapital qiymatini ob'ektiv ravishda o'lchaydi, bu esa biznesni kengaytirishning fundamental salohiyatini va haddan tashqari yuqori baholangan kotirovkalar xavflarini baholash imkonini beradi. Alterity Therapeutics (ATHE) kompaniyasining operatsion sof foydasini tahlil qilish, kompaniyaning moliyaviy barqarorligini Parkinson kasalligi terapiyasi uchun innovatsion dori vositalarini ishlab chiqishdagi yutuqlari va erta bosqichdagi klinik sinovlar natijalarining e'lon qilinishi bilan qiyoslab baholashga yordam beradi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|Kompaniyaning sof foydasi ACAD (ACADIA Pharma)|Xenon Pharmaceuticals Inc - Sof daromad|Soliqlar to‘langandan keyingi foyda VKTX (Viking Therapeutics Corp)|Supernus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Harmony Biosciences Inc - Yakuniy foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|Amylyx Corp (AMLX) - Sof moliyaviy natija|Sof daromad TRVI (Trevi Therapeutics)|Soliqlar to‘langandan keyingi foyda PRAX|Anavex Life Sciences Corp. - Sof daromad|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA: Sof daromad|Yakuniy foyda ALEC (Alector, Inc.)|ANNX (Annexon, Inc.) - Sof daromad|OMER: Soliqlar to‘langandan keyingi foyda|NGNE (Neurogene) - Sof foyda|ACIU: Yakuniy foyda|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Scilex Holding Company SCLX|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|CGTX - Sof foyda|Inhibikase (IKT) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda SAVA (Cassava Pharma)|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof daromadi Coya COYA|Sof daromad VTGN (Vistagen Therapeutics)|Sof foyda ovidrx.com (OVID)|Acumen Pharma - Sof daromad|Soliqlar to‘langandan keyingi foyda CRVO (CervoMed Corporation)|Clene Nanomedicine - Sof foyda|Sof moliyaviy natija PepGen Inc. PEPG|JUNS: Sof foyda|Sof daromad Relmada Therapeutics Inc|Kompaniyaning sof foydasi Annovis Bio Corp|Grace Tx (GRCE) - Sof moliyaviy natija|Sof foyda AIFF|Sof foyda anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Sof daromad|Soliqlar to‘langandan keyingi foyda RVPH (Reviva Pharmaceuticals Holdings Inc.)|MetaVia, Inc. - Sof foyda|Yakuniy foyda NRXS (NeurAxis Inc)|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof foyda ATHA|ADXN - Kompaniyaning sof daromadi|Alzamend Neuro - Sof daromad|Sof foyda Cyclerion Therapeutics Inc. CYCN|PTIX - Kompaniyaning sof foydasi|Yakuniy foyda KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|BCLI (Brainstorm Cell) - Sof foyda|Sof foyda caratherapeutics.com|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|Kompaniyaning sof foydasi ELYM (eliemtx.com)|Intra-Cellular Therapies, Inc. - Sof daromad|Soliqlar to‘langandan keyingi foyda LBPH (Longboard)|Marinus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sage Therapeutics Inc. - Yakuniy foyda|SNPX (Neurotrope) - Sof foyda|Trevena Inc (TRVN) - Sof moliyaviy natija|Sof daromad VIGL (Vigil Neuroscience)|Soliqlar to‘langandan keyingi foyda WENA|Cerevel Therapeutics, Inc. - Sof daromad